Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a placebo-controlled study evaluating the effectiveness of medication in elderly subjects with Major Depressive Disorder (MDD).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| bupropion XL | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Montgomery-Asberg Depression Rating Scale |
| Measure | Description | Time Frame |
|---|---|---|
| Montgomery-Asberg Depression Rating Scale Clinical Global Impression Improvement Scale Clinical Global Impression Severity Scale Hamilton Anxiety Rating Scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| GSK Clinical Trials | GlaxoSmithKline | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Caboolture | Queensland | 4510 | Australia | ||
| GSK Investigational Site |
| ID | Term |
|---|---|
| D003865 | Depressive Disorder, Major |
| D003863 | Depression |
| ID | Term |
|---|---|
| D003866 | Depressive Disorder |
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |
| D001526 | Behavioral Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Everton Park |
| Queensland |
| 4053 |
| Australia |
| GSK Investigational Site | New Farm | Queensland | 4005 | Australia |
| GSK Investigational Site | St Albans | Victoria | 3021 | Australia |
| GSK Investigational Site | Liège | 4000 | Belgium |
| GSK Investigational Site | Mont-Godinne | 5530 | Belgium |
| GSK Investigational Site | Montignies-sur-Sambre | 6061 | Belgium |
| GSK Investigational Site | Mikkeli | 50100 | Finland |
| GSK Investigational Site | Amersfoort | 3818 ES | Netherlands |
| GSK Investigational Site | Grubbenvorst | 5971 BB | Netherlands |
| GSK Investigational Site | Hilversum | 1211 PA | Netherlands |
| GSK Investigational Site | Hoogvliet | 3192 JN | Netherlands |
| GSK Investigational Site | Wildervank | 9648 BE | Netherlands |
| GSK Investigational Site | Oslo | 0407 | Norway |
| GSK Investigational Site | Moscow | 115522 | Russia |
| GSK Investigational Site | Moscow | 119992 | Russia |
| D001519 |
| Behavior |